Free Trial

Profound Medical (PROF) News Today

Profound Medical logo
$7.35
+0.08 (+1.10%)
(As of 11/1/2024 ET)
Profound Medical (PROF) to Release Quarterly Earnings on Thursday
Profound Medical Corp. stock logo
Profound Medical (NASDAQ:PROF) Trading Down 0.1% - Here's What Happened
Profound Medical (NASDAQ:PROF) Trading Down 0.1% - Should You Sell?
Lake Street Issues a Buy Rating on Profound Medical (PRN)
Rashed Dewan Bought 41% More Shares In Profound Medical
Profound Medical Corp. stock logo
Brokers Offer Predictions for Profound Medical Corp.'s FY2027 Earnings (NASDAQ:PROF)
Profound Medical Corp. (NASDAQ:PROF - Free Report) - Stock analysts at Raymond James increased their FY2027 EPS estimates for Profound Medical in a research report issued to clients and investors on Friday, August 9th. Raymond James analyst R. Sarugaser now expects that the company will earn $1.8
Profound Medical Corp. stock logo
Profound Medical (NASDAQ:PROF) Announces Quarterly Earnings Results
Profound Medical (NASDAQ:PROF - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.28) earnings per share for the quarter, hitting the consensus estimate of ($0.28). The firm had revenue of $2.23 million during the quarter, compared to analysts' expectations of $2.50 million. Profound Medical had a negative return on equity of 70.08% and a negative net margin of 386.63%. During the same period in the previous year, the business posted ($0.35) EPS.
Profound Medical earnings preview: what Wall Street is expecting
Profound Medical Corp. stock logo
Silvercrest Asset Management Group LLC Cuts Stock Holdings in Profound Medical Corp. (NASDAQ:PROF)
Silvercrest Asset Management Group LLC reduced its position in shares of Profound Medical Corp. (NASDAQ:PROF - Free Report) by 77.6% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,001 shares of the comp
Profound Medical Corp. stock logo
Profound Medical (NASDAQ:PROF) Now Covered by Analysts at Lake Street Capital
Lake Street Capital started coverage on Profound Medical in a research report on Tuesday. They set a "buy" rating and a $16.50 price target on the stock.
Get Profound Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter.

625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

PROF Media Mentions By Week

PROF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PROF
News Sentiment

0.00

0.43

Average
Medical
News Sentiment

PROF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PROF Articles
This Week

2

3

PROF Articles
Average Week

Get Profound Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:PROF) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners